Literature DB >> 14252273

THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.

D J FINNEY.   

Abstract

Keywords:  AUTOMATIC DATA PROCESSING; CLINICAL RESEARCH; COMPUTERS; DRUGS; MEDICAL RECORDS; STATISTICS; TOXICOLOGIC REPORT; TOXICOLOGY

Mesh：

Substances：

Year:  1965        PMID： 14252273     DOI： 10.1016/0021-9681(65)90054-8

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN： 0021-9681


× No keyword cloud information.
  22 in total

1.  Postmarketing studies: the work of the Drug Safety Research Unit.

Authors:  D J Finney
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

Review 2.  Design issues for drug epidemiology.

Authors:  A D McMahon; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

3.  Use of measures of disproportionality in pharmacovigilance: three Dutch examples.

Authors:  Antoine C G Egberts; Ronald H B Meyboom; Eugène P van Puijenbroek
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Pharmacovigilance.

Authors:  I Ralph Edwards
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

5.  Signal detection: historical background.

Authors:  Toine C G Egberts
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 6.  Detection of drug-induced disease.

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

7.  The case for recording events in clinical trials.

Authors:  D C Skegg; R Doll
Journal:  Br Med J       Date:  1977-12-10

8.  Assessment of adverse drug reactions in psychiatric hospitals.

Authors:  R Grohmann; H Hippius; B Müller-Oerlinghausen; E Rüther; J Scherer; L G Schmidt; A Strauss; B Wolf
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.

Authors:  W Schiess; D Welzel; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Prospective observational study of adverse drug reactions to diclofenac in children.

Authors:  Joseph F Standing; Kuan Ooi; Simon Keady; Richard F Howard; Imogen Savage; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.